Hot Medical Stocks To Own Right Now

Wall Street brokerages forecast that Merit Medical Systems, Inc. (NASDAQ:MMSI) will announce earnings per share (EPS) of $0.38 for the current quarter, Zacks reports. Three analysts have made estimates for Merit Medical Systems’ earnings. The lowest EPS estimate is $0.35 and the highest is $0.43. Merit Medical Systems reported earnings of $0.31 per share during the same quarter last year, which would indicate a positive year over year growth rate of 22.6%. The firm is expected to announce its next earnings results on Wednesday, April 24th.

According to Zacks, analysts expect that Merit Medical Systems will report full-year earnings of $2.02 per share for the current year, with EPS estimates ranging from $1.99 to $2.07. For the next fiscal year, analysts anticipate that the company will post earnings of $2.35 per share, with EPS estimates ranging from $2.30 to $2.44. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Merit Medical Systems.

Hot Medical Stocks To Own Right Now: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

  • [By Logan Wallace]

    ILLEGAL ACTIVITY WARNING: “Cyclacel Pharmaceuticals (CYCC) Sees Unusually-High Trading Volume” was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/4199574/cyclacel-pharmaceuticals-cycc-sees-unusually-high-trading-volume.html.

Hot Medical Stocks To Own Right Now: BlueLinx Holdings Inc.(BXC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Bitcedi (CURRENCY:BXC) traded 0.7% lower against the US dollar during the twenty-four hour period ending at 19:00 PM E.T. on May 20th. One Bitcedi coin can currently be bought for $0.0099 or 0.00000109 BTC on popular cryptocurrency exchanges. Bitcedi has a market capitalization of $57,027.00 and approximately $0.00 worth of Bitcedi was traded on exchanges in the last 24 hours. In the last seven days, Bitcedi has traded down 28.3% against the US dollar.

  • [By Shane Hupp]

    JBF Capital Inc. increased its holdings in shares of BlueLinx Holdings Inc. (NYSE:BXC) by 14.3% in the second quarter, HoldingsChannel reports. The firm owned 31,900 shares of the construction company’s stock after acquiring an additional 4,000 shares during the period. JBF Capital Inc.’s holdings in BlueLinx were worth $1,197,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Bitcedi (BXC) is a proof-of-work (PoW) coin that uses the
    Cryptonight hashing algorithm. Its launch date was May 16th, 2016. Bitcedi’s total supply is 9,616,277 coins and its circulating supply is 5,756,371 coins. Bitcedi’s official website is bitcedi.org. Bitcedi’s official Twitter account is @bitcedis and its Facebook page is accessible here.

  • [By Max Byerly]

    Bitcedi (BXC) is a proof-of-work (PoW) coin that uses the
    Cryptonight hashing algorithm. Its launch date was May 16th, 2016. Bitcedi’s total supply is 9,616,277 coins and its circulating supply is 5,756,371 coins. Bitcedi’s official Twitter account is @bitcedis and its Facebook page is accessible here. The official website for Bitcedi is bitcedi.org.

Hot Medical Stocks To Own Right Now: Cowen Group, Inc.(COWN)

Advisors’ Opinion:

  • [By Max Byerly]

    Thompson Siegel & Walmsley LLC reduced its stake in Cowen Group (NASDAQ:COWN) by 6.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 750,063 shares of the financial services provider’s stock after selling 50,848 shares during the period. Thompson Siegel & Walmsley LLC owned 2.54% of Cowen Group worth $9,900,000 at the end of the most recent quarter.

  • [By Sean Williams]

    In fact, the real possibility of users substituting cannabis for alcohol is one reason why investment firm Cowen Group (NASDAQ:COWN), which is arguably more bullish than any other investment firm on the legal marijuana industry, increased its long-term outlook on marijuana sales by 50%, or $25 billion, to $75 billion. It’s worth pointing out that Cowen’s original estimate calling for $50 billion in annual sales only ran until 2026, and the new estimate extends until 2030. Still, that’s a lofty target for an industry that did “only” $9.7 billion in legal sales in 2017, according to ArcView Market Research.

  • [By Max Byerly]

    Cowen Inc Class A (NASDAQ:COWN) Director Peter A. Cohen sold 5,000 shares of the company’s stock in a transaction dated Friday, June 15th. The stock was sold at an average price of $15.23, for a total transaction of $76,150.00. Following the completion of the sale, the director now owns 698,095 shares in the company, valued at approximately $10,631,986.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Sean Williams]

    According to a new note published this past week by investment firm Cowen (NASDAQ:COWN), the total cannabis market could generate as much as $75 billion in gross annual sales by 2030, up from a previous forecast of $50 billion by 2026.

Hot Medical Stocks To Own Right Now: Sigma Designs, Inc.(SIGM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get Arcturus Therapeutics alerts:

    Don’t Miss This Stock: Arcturus Therapeutics Ltd. (ARCT),Issuer Direct Corporation (ISDR) (bitcoinpriceupdate.review) Blustering Stocks: Camtek Ltd. (NASDAQ:CAMT), Attis Industries, Inc. (NASDAQ:ATIS), Arcturus Therapeutics Ltd … (journalfinance.net) Digging Into the Earnings & Quant Data For These Shares: Arcturus Therapeutics Ltd. (NasdaqGM:ARCT), Lumber … (zeelandpress.com) Average True Range to Consider Before Investment Blink Charging Co. (NASDAQ:BLNK), Inuvo, Inc. (NYSE:INUV … (stocksnewspoint.com) Extremely Informative stocks: Sigma Designs, Inc. (NASDAQ:SIGM), Attis Industries, Inc. (NASDAQ:ATIS), Arcturus … (thestreetpoint.com)

    Shares of Arcturus Therapeutics stock traded up $0.05 during trading on Friday, hitting $8.10. 32,713 shares of the stock traded hands, compared to its average volume of 14,625. The firm has a market capitalization of $86.38 million, a PE ratio of -2.29 and a beta of 1.18. Arcturus Therapeutics has a 52 week low of $4.78 and a 52 week high of $15.19.

  • [By Steve Symington]

    Data source: Silicon Laboratories.

    What happened with Silicon Labs this quarter?
    Revenue was above the high end of guidance provided in late January, which called for a range of $196 million to $202 million. On an adjusted (non-GAAP) basis, which excludes items like equity compensation and acquisition costs, net income was $38.3 million, or $0.87 per share — also above guidance for adjusted earnings per share of between $0.73 and $0.79. IoT revenue grew 17% year over year to $103 million. Infrastructure revenue jumped 37% year over year to $49 million. Broadcast revenue declined 3% to $36 million. Access revenue fell 6% to $17 million. Subsequent to the end of the quarter, on April 18, 2018, Silicon Labs closed its $240 million acquisition of Sigma Designs’ (NASDAQ:SIGM) Z-Wave business. Silicon Labs had initially agreed to acquire all of Sigma Designs this past December for $282 million, but amended the deal last quarter to include only its Z-Wave business after certain closing conditions weren’t met. In any case, the purchase significantly expands Silicon Labs’ position in mesh networking for smart homes.

    What management had to say

    Silicon Labs CEO Tyson Tuttle said:

Leave a Reply

Your email address will not be published. Required fields are marked *